4-Hydroxynonenal Regulates TNF-α Gene Transcription Indirectly via ETS1 and microRNA-29b in Human Adipocytes Induced From Adipose Tissue-Derived Stromal Cells

Anatomical Record

Volumn 299, Issue 8, 2016, Pages 1145-1152

  Zhang, Xi Mei ^a   Guo, Lin ^b   Huang, Xiang ^a   Li, Qiu Ming ^a   Chi, Mei Hua ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b THE SECOND AFFILIATED HOSPITAL OF HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

adipose stem cells; inflammation; miRNA; obesity; stromal cells

Indexed keywords

4 HYDROXYNONENAL; MICRORNA 29B; TRANSCRIPTION FACTOR ETS 1; TRANSCRIPTION FACTOR SP1; TUMOR NECROSIS FACTOR ALPHA; 4-HYDROXY-2-NONENAL; ALDEHYDE; CYSTEINE PROTEINASE INHIBITOR; ETS1 PROTEIN, HUMAN; MICRORNA; MIRN29 MICRORNA, HUMAN; SP1 PROTEIN, HUMAN; TUMOR NECROSIS FACTOR;

ADIPOCYTE; ADIPOSE TISSUE CELL; ADIPOSE TISSUE DERIVED STROMAL CELL; ADULT; ARTICLE; BLOOD LEVEL; CHROMATIN IMMUNOPRECIPITATION; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; LUCIFERASE ASSAY; MALE; MIDDLE AGED; OBESITY; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STROMA CELL; SUBCUTANEOUS WHITE ADIPOSE TISSUE; TISSUE LEVEL; TRANSCRIPTION REGULATION; ADIPOSE TISSUE; CASE CONTROL STUDY; CELL CULTURE; CYTOLOGY; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; INFLAMMATION; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PROMOTER REGION;

ADIPOSE TISSUE; ALDEHYDES; CASE-CONTROL STUDIES; CELLS, CULTURED; CYSTEINE PROTEINASE INHIBITORS; FEMALE; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATION; MALE; MICRORNAS; MIDDLE AGED; OBESITY; PROMOTER REGIONS, GENETIC; PROTO-ONCOGENE PROTEIN C-ETS-1; SP1 TRANSCRIPTION FACTOR; STROMAL CELLS; TRANSCRIPTION, GENETIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84971233880     PISSN: 19328486     EISSN: 19328494     Source Type: Journal    
DOI: 10.1002/ar.23371     Document Type: Article

References (20)

1. Arner E, Mejhert N, Kulyte A, Balwierz PJ, Pachkov M, Cormont M, Lorente-Cebrian S, Ehrlund A, Laurencikiene J, Heden P, Dahlman-Wright K, Tanti JF, Hayashizaki Y, Ryden M, Dahlman I, van Nimwegen E, Daub CO, Arner P. 2012. Adipose tissue microRNAs as regulators of CCL2 production in human obesity. Diabetes 61:1986–1993.
2. Bluher M. 2014. Adipokines—removing road blocks to obesity and diabetes therapy. Mol Metab 3:230–240.
3. Chen L, Zhou JP, Kuang DB, Tang J, Li YJ, Chen XP. 2013. 4-HNE increases intracellular ADMA levels in cultured HUVECs: evidence for miR-21-dependent mechanisms. PLoS One 8:e64148.
4. Fain JN. 2010. Release of inflammatory mediators by human adipose tissue is enhanced in obesity and primarily by the nonfat cells: a review. Mediators Inflamm 2010:513948.
5. Ge Q, Brichard S, Yi X, Li Q. 2014. microRNAs as a new mechanism regulating adipose tissue inflammation in obesity and as a novel therapeutic strategy in the metabolic syndrome. J Immunol Res 2014:987285.
6. Heneghan HM, Miller N, McAnena OJ, O'Brien T, Kerin MJ. 2011. Differential miRNA expression in omental adipose tissue and in the circulation of obese patients identifies novel metabolic biomarkers. J Clin Endocrinol Metab 96:E846–E850.
7. Hotamisligil GS, Spiegelman BM. 1994. Tumor necrosis factor alpha: a key component of the obesity-diabetes link. Diabetes 43:1271–1278.
8. Hotamisligil GS, Shargill NS, Spiegelman BM. 1993. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 259:87–91.
9. Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM. 1995. Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J Clin Invest 95:2409–2415.
10. Kang SS, Kurti A, Fair DA, Fryer JD. 2014. Dietary intervention rescues maternal obesity induced behavior deficits and neuroinflammation in offspring. J Neuroinflamm 11:156.
11. Lee YH, Nair S, Rousseau E, Allison DB, Page GP, Tataranni PA, Bogardus C, Permana PA. 2005. Microarray profiling of isolated abdominal subcutaneous adipocytes from obese vs non-obese Pima Indians: increased expression of inflammation-related genes. Diabetologia 48:1776–1783.
12. Mathur SK, Jain P, Mathur P. 2011. Microarray evidences the role of pathologic adipose tissue in insulin resistance and their clinical implications. J Obes 2011:587495.
13. Ouchi N, Parker JL, Lugus JJ, Walsh K. 2011. Adipokines in inflammation and metabolic disease. Nat Rev Immunol 11:85–97.
14. Ramirez Alvarado MM, Sanchez Roitz C. 2012. Tumor necrosis factor-alpha, insulin resistance, the lipoprotein metabolism and obesity in humans. Nutr Hosp 27:1751–1757.
15. Tarantino G, Savastano S, Colao A. 2010. Hepatic steatosis, low-grade chronic inflammation and hormone/growth factor/adipokine imbalance. World J Gastroenterol 16:4773–4783.
16. Tzanavari T, Giannogonas P, Karalis KP. 2010. TNF-alpha and obesity. Curr Dir Autoimmun 11:145–156.
17. Wang Z, Cheng Z, Cristofaro V, Li J, Xiao X, Gomez P, Ge R, Gong E, Strle K, Sullivan MP, Adam RM, White MF, Olumi AF. 2012. Inhibition of TNF-alpha improves the bladder dysfunction that is associated with type 2 diabetes. Diabetes 61:2134–2145.
18. Zampetaki A, Kiechl S, Drozdov I, Willeit P, Mayr U, Prokopi M, Mayr A, Weger S, Oberhollenzer F, Bonora E, Shah A, Willeit J, Mayr M. 2010. Plasma microRNA profiling reveals loss of endothelial miR-126 and other microRNAs in type 2 diabetes. Circ Res 107:810–817.
19. Zhang X, Wang Z, Li J, Gu D, Li S, Shen C, Song Z. 2013. Increased 4-hydroxynonenal formation contributes to obesity-related lipolytic activation in adipocytes. PLoS One 8:e70663.
20. Zhang XM, Guo L, Chi MH, Sun HM, Chen XW. 2015. Identification of active miRNA and transcription factor regulatory pathways in human obesity-related inflammation. BMC Bioinform 16:76.